Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
RAVE (RaveDAO) sees 71.5% volatility in 24 hours: Whale activity and low circulating supply drive speculative swings

RAVE (RaveDAO) sees 71.5% volatility in 24 hours: Whale activity and low circulating supply drive speculative swings

Bitget PulseBitget Pulse2026/04/22 16:02
Show original
By:Bitget Pulse

Volatility Summary

Over the past 24 hours, the price of RAVE rebounded from a low of $1.01713 to a high of $1.744, currently quoted at $1.1196. The amplitude reached 71.5%, displaying characteristics of extreme volatility. The 24-hour trading volume was approximately $307 million, surpassing its market capitalization of about $251 million. There was a significant net inflow of funds, accompanied by high leveraged futures positions.

Brief Analysis of Cause for Abnormal Price Movement

- Low circulating supply (only about 248 million in circulation, total supply 1 billion) and 98% of tokens concentrated in the top 10 wallets make the price vulnerable to whale manipulation, triggering a short squeeze.

- On-chain data shows that over the past 24 hours, whales transferred millions of RAVE to exchanges such as Bitget, leading to a transaction volume surge of more than 1000% and a leveraged positions spike of 429%, all amplifying volatility.

- Exchanges have launched manipulation investigations, continuing the dead-cat bounce following the 90% crash from the previous day.

Market Opinion and Outlook

Mainstream sentiment within the community is negative, calling it a typical "pump-and-dump." Analysts like ZachXBT point out that team wallets control over 95% of the supply, warning retail investors to hedge their risks. Exchanges such as Binance and Bitget are conducting investigations, making short-term rebounds unlikely to hold. Risk warnings are focused on manipulation and liquidity drain.

Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, provided for informational reference only.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23